Volume:
779,382
Avg Vol (1m):
1,126,303
Market Cap $:
17.50 Bil
Enterprise Value $:
18.55 Bil
PE Ratio:
35.57
PB Ratio:
155.56
Financial Strength | 5/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.46 | ||
| Equity-to-Asset | 0.02 | ||
| Debt-to-Equity | 17.2 | ||
| Debt-to-EBITDA | 2.47 | ||
| Interest Coverage | 9.6 | ||
| Piotroski F-Score | 7 | ||
| Altman Z-Score | 4.67 | ||
| Beneish M-Score | -2.85 | ||
| WACC vs ROIC | |||
Profitability Rank | 9/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 19.18 | ||
| Net Margin % | 15.59 | ||
| ROE % | 357.22 | ||
| ROA % | 11.08 | ||
| ROC (Joel Greenblatt) % | 149.19 | ||
| 3-Year Revenue Growth Rate | 12.2 | ||
| 3-Year EBITDA Growth Rate | 7.1 | ||
| 3-Year EPS without NRI Growth Rate | 205.7 |
Valuation Rank | 5/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 35.57 | ||
| Forward PE Ratio | 22.27 | ||
| PE Ratio without NRI | 35.57 | ||
| Price-to-Owner-Earnings | 36.01 | ||
| PB Ratio | 155.56 | ||
| PS Ratio | 5.55 | ||
| Price-to-Free-Cash-Flow | 20.29 | ||
| Price-to-Operating-Cash-Flow | 19.19 | ||
| EV-to-EBIT | 29.93 | ||
| EV-to-EBITDA | 23.82 | ||
| EV-to-Revenue | 5.73 | ||
| PEG Ratio | 3.29 | ||
| Shiller PE Ratio | 52.84 | ||
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.92 | ||
| Days Inventory | 12.73 | ||
| Days Sales Outstanding | 77.98 | ||
| Days Payable | 74.02 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Dividend Yield % | 1 | ||
| Dividend Payout Ratio | 0.35 | ||
| Forward Dividend Yield % | 1.04 | ||
| 5-Year Yield-on-Cost % | 1 | ||
| 3-Year Average Share Buyback Ratio | 5.2 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Intrinsic-Value-Projected-FCF | 1.46 | ||
| Price-to-Intrinsic-Value-DCF (Earnings Based) | 2.19 | ||
| Price-to-Median-PS-Value | 1.2 | ||
| Price-to-Peter-Lynch-Fair-Value | 2.72 | ||
| Earnings Yield (Greenblatt) % | 3.33 | ||
| Forward Rate of Return (Yacktman) % | 17.43 |